Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.
Sci Rep
; 12(1): 20373, 2022 11 27.
Article
en En
| MEDLINE
| ID: mdl-36437298
ABSTRACT
Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65-84 years old) early aftesr a first booster dose. An increase in SARS-CoV-2 neutralizing antibodies was shown in individuals not previously infected without evidence of an age-related effect, with lower increase in those infected before a single dose of primary vaccination. Of note, humoral response was observed only starting from the 5th day after the boost.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Vacunas Virales
/
COVID-19
Límite:
Aged
/
Aged80
/
Humans
Idioma:
En
Año:
2022
Tipo del documento:
Article